GS
RYZB

George Soros’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

George Soros’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,000
Closed -$444K – 279
2023
Q3 		$444K Buy
+20,000
New +$420K 0.01% 206

Other funds holding RYZB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

George Soros's RYZB Position: Q4 2023 in Review

George Soros sold out of RayzeBio, Inc. Common Stock (RYZB) in Q4 2023, closing a stake of 20,000 shares — an estimated $444K sold.

George Soros first reported a position in RYZB in Q3 2023 and held it in 1 quarter. The position peaked at $444K in Q3 2023. 107 funds tracked by Wall St. Rank hold RYZB as of Q4 2023.

  • George Soros reported no remaining RayzeBio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • George Soros sold 20,000 RayzeBio, Inc. Common Stock shares in Q4 2023, an estimated $444K.
  • George Soros first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • George Soros's RayzeBio, Inc. Common Stock position peaked at $444K in Q3 2023.
  • 107 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q4 2023.

Based on Soros Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.